Latest Breaking News On - Seriesc warrant - Page 4 : comparemela.com

Biodexa Pharmaceuticals (BDRX) Announces 22 14M Share Offering at $0 15/sh

Biodexa Pharmaceuticals (BDRX) Announces 22 14M Share Offering at $0 15/sh
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesNew yorkExchange commissionProspectus departmentCompany adssPlacement agency agreementBiodexa pharmaceuticals plcstephen stampCompany on englishPlacement the companyDirectors of the companyLadenburg thalmann coBiodexa pharmaceuticalsHerrington sutcliffeEdison group us investor relations alyssa factortelBrown rudnick

SENESTECH, INC : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Other Events, Financial Statements and Exhibits (form 8-K)

Item 1.01. Entry into a Material Definitive Agreement. On April 10, 2023, we entered into a Securities Purchase Agreement , pursuant to which we agreed to sell and issue in. | April 12, 2023

United statesGreenberg traurigHc wainwright coMaterial definitiveSecurities purchase agreementRegistered direct offeringSeriesc warrantsPurchase agreementPlacement agentCommon stockPlacement agent warrantsSecurities actCurrent reportPrivate placementExhibit numberSeriesc warrant

Form 424B3 Quoin Pharmaceuticals,

Form 424B3 Quoin Pharmaceuticals,
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesNew jerseyTel avivSan diegoEast hanoverGordon dunnExchange commission onQuoin pharmaceuticals incEncellx incCellect biotherapeutics ltdQuoin incCompany or quoinQuoin pharmaceuticals announces pricingCompany annual report on formCellect biotechnology ltd